Miltenyi Bioindustry is a global Contract Development and Manufacturing Organization (CDMO) specialising in the development and manufacturing of cell and gene therapy (CGT) products. With over 25 years of expertise, the company offers advanced technologies and comprehensive services to accelerate the translation of therapies from pre-clinical stages to commercial scale.

Miltenyi Bioindustry provides end-to-end support for CGT development, including process development, manufacturing, and regulatory guidance. As part of Miltenyi Biotec, the company leverages cutting-edge technologies for lentiviral vector (LVV) production and cell therapy manufacturing.

Key Products and Services

• Cell and gene therapy process development
• GMP manufacturing for clinical and commercial applications
• Lentiviral vector optimization and manufacturing
• Regulatory support for market approval
• Closed, integrated solutions for clinical trials
• Scalable platforms for lentiviral vector production

Miltenyi Bioindustry is dedicated to advancing the CGT field by making life-changing therapies more accessible and affordable through its expert services, technologies, and extensive industry knowledge.